<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03816072</url>
  </required_header>
  <id_info>
    <org_study_id>METC 2018_230</org_study_id>
    <nct_id>NCT03816072</nct_id>
  </id_info>
  <brief_title>Quantification of Dynamic and Static Cerebral Autoregulation (CA) Under Anaesthesia</brief_title>
  <acronym>SAMBA</acronym>
  <official_title>Simultaneous Quantification of Dynamic and Static Cerebral Autoregulation (CA) at Different Steady-state Mean Blood Pressures Under Anaesthesia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cerebral autoregulation (CA) is the mechanism by which the brain vasculature maintains
      constancy of cerebral blood flow (CBF). Reliable direct measurements of CBF at different
      blood pressure levels are difficult because they are invasive and time-consuming. This type
      of measurement to quantify CA is generally referred to as static cerebral autoregulation
      (sCA). Alternatively, it is possible to measure CA indirectly from blood pressure
      oscillations. Dynamic cerebral autoregulation (dCA) measures how quickly the cerebral vessels
      react to a change in blood pressure to normalize CBF. Since the introduction of transcranial
      Doppler ultrasound (TCD), it has become possible to estimate CBF velocity relatively easy,
      which in turn correlates well with CBF changes. This method is widely used to quantify dCA.
      However, it is not clear how sCA correlates with dCA over a range of physiologic mean blood
      pressure (MBP). It is important to compare different methods of assessing CA, because
      impaired CA may result in increased risk of perioperative complications such as stroke. In
      this study, we were interested in establishing the relationship between sCA and dCA during
      surgery under general anesthesia. We aim to compare these methods during propofol and
      sevoflurane anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 7, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All patients will receive the same interventions.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in dCA after several MBP-increasing steps.</measure>
    <time_frame>Intraoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Differences in dCA between sevoflurane and propofol at different steady-state MBP's.</measure>
    <time_frame>Intraoperatively</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Cerebral Autoregulation</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ASA-I/II patients undergoing elective, non-cardiothoracic surgery with intravenous anaesthesia (propofol).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ASA-I/II patients undergoing elective, non-cardiothoracic surgery with inhalational anaesthesia (sevoflurane).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenylephrine infusion</intervention_name>
    <description>Correction of anesthesia induced hypotension with phenylephrine to obtain sCA and dCA measurements at 60, 70, 80, 90 and 100 mmHg mean blood pressure. This is achieved by stepwise increases in phenylephrine infusion dose.</description>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_label>Sevoflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mechanical ventilation</intervention_name>
    <description>Patientes are mechanically ventilated at 6 bpm to obtain low frequency blood pressure oscillations (~0.1 Hz).</description>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_label>Sevoflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Sevoflurane</description>
    <arm_group_label>Sevoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA-I or ASA-II, willing and able to give written informed consent, scheduled for
             elective, non-cardiothoracic surgery under general anaesthesia and age 18 years and
             above.

        Exclusion Criteria:

          -  Patient related

               -  Unable/ unwilling to participate

               -  ASA-III or higher

               -  Age &lt; 18 years

               -  History of: uncontrolled hypertension, diabetes, Parkinson's disease,
                  uncontrolled cardiac arrhythmia, Pure autonomic failure (formerly called
                  idiopathic orthostatic hypotension), Multiple system atrophy with autonomic
                  failure (formerly called Shy-Drager syndrome), Addison's disease and
                  hypopituitarism, pheochromocytoma, peripheral autonomic neuropathy (e.g., amyloid
                  neuropathy, idiopathic autonomic neuropathy), known cardiomyopathy, extreme left
                  ventricle hypertrophy or ejection fraction &lt; 30%, proven or suspected allergy for
                  any of the medication used during induction of anaesthesia, malignant
                  hyperthermia.

               -  Unability to record transcranial Doppler ultrasound due to anatomical variance
                  (~5% of population)

               -  Contra-indications for intravenous or inhalational anaesthesia.

               -  Contra-indications for phenylephrine: severe hypertension, peripheral vascular
                  illness, severe hyperthyroidism

               -  Simultaneous use of MAO-inhibitors, dopaminergic or vasoconstrictor ergot
                  alkaloids (bromocriptine, cabergoline, pergolide, ergotamine, methylergometrine,
                  methysergide), linezolid, tricyclic antidepressants, serotonin-norepinephrine
                  reuptake inhibitors, digoxin, quinidine, oxytocin.

          -  Surgery related

               -  Day case surgery

               -  Laparoscopy with CO2 insufflation

               -  Extreme positioning during surgery (head-down/up tilt, lateral decubitus
                  position, prone)

               -  Surgery &lt; 60 minutes.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeroen Hermanides, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Amsterdam UMC, location AMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeroen Hermanides, Dr.</last_name>
    <phone>+31 20 5669111</phone>
    <email>j.hermanides@amc.uva.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Amsterdam UMC, location AMC</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord-Holland</state>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeroen Hermanides, Dr.</last_name>
      <phone>+31 20 5669111</phone>
      <email>j.hermanides@amc.uva.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 21, 2019</study_first_submitted>
  <study_first_submitted_qc>January 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2019</study_first_posted>
  <last_update_submitted>January 24, 2019</last_update_submitted>
  <last_update_submitted_qc>January 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>Niek Sperna Weiland</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

